Cash flows from investing activities:
Proceeds from sale of intellectual
property 400 -
Investment in IPR&D - (660)
Cash acquired in merger - 4
--------- --------
Net cash used in investing activities 400 (656)
Cash flows from financing activities:
Proceeds from sale of common stock, net
of fees and offering costs, $49 and
$47 respectively 1,597 46
Proceeds from public offering of common
stock and warrants net of underwriters
discount and offering costs of $2,075
and $727 respectively 21,456 5,303
Proceeds from induced exercise of
warrants, net of costs of $359 3,526 -
Proceeds from voluntary exercise of
warrants 1,223 5
Payments made on notes payable (1,650) -
Cash paid for fractional shares (10)
--------- ------------
Net cash provided by financing
activities 26,142 5,354
Effect of exchange rate changes on cash - (4)
--------- --------
Net change in cash 1,293 (10,582)
Cash and cash equivalents at beginning of
year 1,285 11,867
--------- --------
Cash and cash equivalents at end of year $ 2,578 $ 1,285
========= ========
Supplemental disclosure of cash flow
information:
Cash paid during period for interest $ 404 $ 15
========= ========
Supplemental disclosure of non-cash
transactions:
Fair value of common stock, stock
options and stock warrants issued as
consideration for asset acquisition $ - $ 9,605
Adjustment for the value offered to
induce warrant exercise $ 9,140 $ -
(END) Dow Jones Newswires
March 26, 2024 16:57 ET (20:57 GMT)
Comments